Manufacturer of Controlled Substances; Notice of Registration, 45786-45787 [E8-17958]
Download as PDF
<![CDATA[
45786
Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices
Drug
Schedule
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Methadone (9250) ........................
Morphine (9300) ...........................
Oxymorphone (9652) ...................
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
II
II
II
II
II
II
II
II
II
II
II
II
The company plans on manufacturing
the listed controlled substances in bulk
for sale to its customers.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than October 6, 2008.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–18047 Filed 8–5–08; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated April 9, 2008, and
published in the Federal Register on
April 16, 2008, (73 FR 20718), Aldrich
Chemical Company, Inc., DBA Isotec,
3858 Benner Road, Miamisburg, Ohio
45342–4304, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedules I and II:
mstockstill on PROD1PC66 with NOTICES
Drug
Schedule
Cathinone (1235) ..........................
Methcathinone (1237) ...................
N-Ethylamphetamine (1475) .........
N,N-Dimethylamphetamine (1480)
Aminorex (1585) ...........................
Gamma
Hydroxybutyric
Acid
(2010).
Methaqualone (2565) ....................
Ibogaine (7260) .............................
VerDate Aug<31>2005
16:46 Aug 05, 2008
I
I
I
I
I
I
I
I
Jkt 214001
Drug
Schedule
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) ......
Mescaline (7381) ..........................
2,5-Dimethoxyamphetamine
(7396).
3,4-Methylenedioxyamphetamine
(7400).
3,4-Methylenedioxy-Nethylamphetamine (7404).
3,4-Methylenedioxy-methamphetamine (7405).
4-Methoxyamphetamine (7411) ....
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
N-Ethyl-1-phenylcyclohexylamine
(7455).
Dihydromorphine (9145) ...............
Normorphine (9313) ......................
Acetylmethadol (9601) ..................
Alphacetylmethadol except levoalphacetylmethadol (9603).
Normethadone (9635) ...................
Norpipanone (9636) ......................
3-Methylfentanyl (9813) ................
Amphetamine (1100) ....................
Methamphetamine (1105) .............
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
1-Phenylcyclohexylamine (7460) ..
Phencyclidine (7471) ....................
Phenylacetone (8501) ...................
1Piperidinocyclohexanecarbonitrile (8603).
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) .................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Isomethadone (9226) ....................
Meperidine (9230) .........................
Meperidine intermediate-A (9232)
Meperidine intermediate-B (9233)
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk, (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ....................
Fentanyl (9801) .............................
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances to produce isotope labeled
standards for drug testing and analysis.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Aldrich Chemical Company to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Aldrich Chemical Company
to ensure that the company’s
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: July 29, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–17956 Filed 8–5–08; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated February 12, 2008
and published in the Federal Register
on February 21, 2008, (73 FR 9593),
Roche Diagnostics Operations, Inc.,
Attn: Regulatory Compliance, 9115
Hague Road, Indianapolis, Indiana
46250, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Drug
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols
(THC)
(7370).
Alphamethadol (9605) ..................
Hydromorphone (9150) .................
Benzoylecgonine (9180) ...............
Methadone (9250) ........................
Morphine (9300) ...........................
Schedule
I
I
I
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances for use in diagnostic
products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Roche Diagnostics Operations, Inc. to
manufacture the listed basic classes of
controlled substances is consistent with
the public interest at this time. DEA has
investigated Roche Diagnostics
Operations, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
E:\FR\FM\06AUN1.SGM
06AUN1
45787
Federal Register / Vol. 73, No. 152 / Wednesday, August 6, 2008 / Notices
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: July 29, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–17958 Filed 8–5–08; 8:45 am]
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: July 29, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–17964 Filed 8–5–08; 8:45 am]
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: July 28, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E8–17972 Filed 8–5–08; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Manufacturer of Controlled
Substances; Notice of Registration
Manufacturer of Controlled
Substances; Notice of Registration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 19, 2008, and
published in the Federal Register on
March 28, 2008, (73 FR 16711), Penick
Corporation, 33 Industrial Road,
Pennsville, New Jersey 08070, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule II:
By Notice dated March 28, 2008, and
published in the Federal Register on
April 4, 2008 (73 FR 18570), Rhodes
Technologies, 498 Washington Street,
Coventry, Rhode Island 02816, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedules I and II:
Drug
Drug
Schedule
mstockstill on PROD1PC66 with NOTICES
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) .................
Diphenoxylate (9170) ....................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ....................
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances as bulk
controlled substance intermediates for
distribution to its customers for further
manufacture or to manufacture
pharmaceutical dosage forms.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Penick Corporation to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Penick Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
VerDate Aug<31>2005
16:46 Aug 05, 2008
Jkt 214001
I
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for conversion and sale to dosage form
manufacturers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Rhodes Technologies to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Rhodes Technologies to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
Frm 00095
Fmt 4703
Drug
Schedule
Tetrahydrocannabinols (7370) ......
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) .................
Hydrocodone (9193) .....................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ....................
Noroxymorphone (9668) ...............
Fentanyl (9801) .............................
PO 00000
By Notice dated March 27, 2008, and
published in the Federal Register on
April 2, 2008 (73 FR 18001), Lonza
Riverside, 900 River Road,
Conshohocken, Pennsylvania 19428,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
schedules I and II:
Sfmt 4703
Gamma
hydroxybutyric
acid
(2010).
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Schedule
I
II
II
The company plans to manufacture
bulk products for finished dosage units
and distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Lonza Riverside to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Lonza Riverside to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
E:\FR\FM\06AUN1.SGM
06AUN1
]]>Agencies
[Federal Register Volume 73, Number 152 (Wednesday, August 6, 2008)]
[Notices]
[Pages 45786-45787]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-17958]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated February 12, 2008 and published in the Federal
Register on February 21, 2008, (73 FR 9593), Roche Diagnostics
Operations, Inc., Attn: Regulatory Compliance, 9115 Hague Road,
Indianapolis, Indiana 46250, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)........... I
Tetrahydrocannabinols (THC) (7370).......... I
Alphamethadol (9605)........................ I
Hydromorphone (9150)........................ II
Benzoylecgonine (9180)...................... II
Methadone (9250)............................ II
Morphine (9300)............................. II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances for use in diagnostic products.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Roche Diagnostics Operations, Inc. to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated Roche Diagnostics Operations, Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection
[[Page 45787]]
and testing of the company's physical security systems, verification of
the company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33, the above named company is
granted registration as a bulk manufacturer of the basic classes of
controlled substances listed.
Dated: July 29, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-17958 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
